Literature DB >> 108182

Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytes.

U Hopf, G Assmann, H E Schaefer, A Capurso.   

Abstract

Isolated mucosal cells from the human jejunum and stomach, cryostat sections from the jejunum, isolated parenchymal liver cells and lymphocytes were investigated for the presence of apolipoprotien A (apoA). Antisera against purified human apoA-I and apoA-II were raised in rabbits and conjugated with fluorescein-isothiocyanate (FITC). Mucosal cells from jejunum and stomach were isolated with pronase from tissue obtained from operated patients. ApoA-I and apoA-II could be demonstrated in isolated mucosal cells as well as in cryostat sections from the jejunum. The fluorescence pattern in isolated jejunal cells was coarse granular. In the radial gel diffusion test the homogenate from mucosal cells of jejunum showed a single precipitation line with anti-apoA-I and with anti-apoA-II, respectively. The reaction was more intensive with anti-apoA-I than with anti-apoA-II. Isolated gastric cells were negative for apoA. Hepatocytes incubated with FITC anti-apoA-I showed a fine granular fluorescence pattern in the cytoplasm. Anti-apoA-II did not react with hepatocytes. There was no evidence for an in vivo fixation of serum-apoA at the surface of isolated mucosal cells from jejunum or isolated hepatocytes. The results support the hypotheses that in man apoA is synthesised in the epithelial cells of the small intestine and in parenchymal liver cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108182      PMCID: PMC1412301          DOI: 10.1136/gut.20.3.219

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

3.  A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow.

Authors:  L S KAPLOW
Journal:  Blood       Date:  1955-10       Impact factor: 22.113

4.  Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay.

Authors:  J B Karlin; D J Juhn; J I Starr; A M Scanu; A H Rubenstein
Journal:  J Lipid Res       Date:  1976-01       Impact factor: 5.922

5.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Rat intestine secretes discoid high density lipoprotein.

Authors:  P H Green; A R Tall; R M Glickman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.

Authors:  M C Cheung; J J Albers
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

8.  The intestine as a source of apolipoprotein A1.

Authors:  R M Glickman; P H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.

Authors:  R L Hamilton; M C Williams; C J Fielding; R J Havel
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

View more
  1 in total

1.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.